# FDA Inspection 992394 - AndersonBrecon, Inc. d.b.a. PCI of Illinois - November 01, 2016

Source: https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc-dba-pci-of-illinois/c64b3188-29ec-46bd-b978-a5b8c24e9683
Source feed: FDA_Inspections

> FDA Inspection 992394 for AndersonBrecon, Inc. d.b.a. PCI of Illinois on November 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992394
- Company Name: AndersonBrecon, Inc. d.b.a. PCI of Illinois
- Inspection Date: 2016-11-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 573193 - 2009-04-02](https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc-dba-pci-of-illinois/3cda111c-f57d-4ee9-a809-c6eaac35d071)

Company: https://www.keypedia.com/companies/andersonbrecon-inc-dba-pci-of-illinois/341c74aa-e9fa-4579-a54b-c31a526686bc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c